We evaluated cytokine levels , tear film break-up time ( TBUT ) , corneal and conjunctival fluorescein staining , biomicroscopic examination of lid margins and meibomian glands , and the Ocular Surface Disease Index before initiating treatment and 1 month and 2 months after treatment .